OneSource Specialty Pharma Limited (NSE:ONESOURCE)
1,325.10
-52.70 (-3.82%)
Oct 23, 2026, 3:29 PM IST
NSE:ONESOURCE Revenue
OneSource Specialty Pharma had revenue of 4.49B INR in the quarter ending June 30, 2026, with 37.20% growth. This brings the company's total for the last twelve months to 15.43B, up 4.29% year-over-year. In the fiscal year ending March 31, 2026, OneSource Specialty Pharma had annual revenue of 14.23B, down -1.49%. That makes OneSource Specialty Pharma the 18,977th largest company in the world by revenue and 1,030th in India.
Revenue (ttm)
15.43B
Revenue Growth
+4.29%
P/S Ratio
10.24
Revenue / Employee
9.22M
Employees
1,674
Market Cap
151.95B
Revenue by Geography
- United States of America 4.93B 34.7%
- India 3.96B 27.9%
- Rest of The World 3.08B 21.7%
- Spain 1.54B 10.8%
- Ireland 699.56M 4.9%
Fiscal year ended Mar 31, 2026 See the full NSE:ONESOURCE breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 14.23B | -215.98M | -1.49% |
| Mar 31, 2025 | 14.45B | 12.73B | 740.50% |
| Mar 31, 2024 | 1.72B | 1.33B | 344.07% |
| Mar 31, 2023 | 387.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
OneSource Specialty Pharma News
- 3 months ago - OneSource Specialty Pharma Transcript: Q1 26/27 - Transcripts
- 3 months ago - OneSource Specialty Pharma Quarterly report: Q1 2027 - Filings
- 3 months ago - OneSource Specialty Pharma Slides: Q1 2027 - Filings
- 5 months ago - OneSource Specialty Pharma Transcript: Q4 25/26 - Transcripts
- 5 months ago - OneSource Specialty Pharma Slides: Q4 2026 - Filings
- 5 months ago - OneSource Specialty Pharma Quarterly report: Q4 2026 - Filings
- 5 months ago - OneSource Specialty Pharma Annual report: Q4 2026 - Filings
- 9 months ago - OneSource Specialty Pharma Transcript: Q3 25/26 - Transcripts